149 related articles for article (PubMed ID: 22529279)
1. Pharmacologic treatment of repetitive behaviors in autism spectrum disorders: evidence of publication bias.
Carrasco M; Volkmar FR; Bloch MH
Pediatrics; 2012 May; 129(5):e1301-10. PubMed ID: 22529279
[TBL] [Abstract][Full Text] [Related]
2. A trial of D-cycloserine to treat stereotypies in older adolescents and young adults with autism spectrum disorder.
Urbano M; Okwara L; Manser P; Hartmann K; Herndon A; Deutsch SI
Clin Neuropharmacol; 2014; 37(3):69-72. PubMed ID: 24824660
[TBL] [Abstract][Full Text] [Related]
3. Evidence-based behavioral interventions for repetitive behaviors in autism.
Boyd BA; McDonough SG; Bodfish JW
J Autism Dev Disord; 2012 Jun; 42(6):1236-48. PubMed ID: 21584849
[TBL] [Abstract][Full Text] [Related]
4. A test for reporting bias in trial networks: simulation and case studies.
Trinquart L; Ioannidis JP; Chatellier G; Ravaud P
BMC Med Res Methodol; 2014 Sep; 14():112. PubMed ID: 25262204
[TBL] [Abstract][Full Text] [Related]
5. The effects of online education on academic success: A meta-analysis study.
Ulum H
Educ Inf Technol (Dordr); 2022; 27(1):429-450. PubMed ID: 34512101
[TBL] [Abstract][Full Text] [Related]
6. Risperidone dosing in children and adolescents with autistic disorder: a double-blind, placebo-controlled study.
Kent JM; Kushner S; Ning X; Karcher K; Ness S; Aman M; Singh J; Hough D
J Autism Dev Disord; 2013 Aug; 43(8):1773-83. PubMed ID: 23212807
[TBL] [Abstract][Full Text] [Related]
7. Cortico-basal ganglia white matter microstructure is linked to restricted repetitive behavior in autism spectrum disorder.
Wilkes BJ; Archer DB; Farmer AL; Bass C; Korah H; Vaillancourt DE; Lewis MH
Mol Autism; 2024 Jan; 15(1):6. PubMed ID: 38254158
[TBL] [Abstract][Full Text] [Related]
8. Common practical questions - and answers - at the British Association for Psychopharmacology child and adolescent psychopharmacology course.
Cortese S; Besag FM; Clark B; Hollis C; Kilgariff J; Moreno C; Nicholls D; Wilkinson P; Woodbury-Smith M; Sharma A
J Psychopharmacol; 2023 Feb; 37(2):119-134. PubMed ID: 36476096
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of antidepressants for global improvement and subdomain symptoms of autism spectrum disorder: a systematic review and meta-analysis.
Liang SC; Sun CK; Fan HY; Chung W; Tzang RF; Hung KC; Chiu HJ; Cheng YS; Yeh PY
J Psychiatry Neurosci; 2022; 47(4):E299-E310. PubMed ID: 35948343
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis.
Siafis S; Çıray O; Wu H; Schneider-Thoma J; Bighelli I; Krause M; Rodolico A; Ceraso A; Deste G; Huhn M; Fraguas D; San José Cáceres A; Mavridis D; Charman T; Murphy DG; Parellada M; Arango C; Leucht S
Mol Autism; 2022 Mar; 13(1):10. PubMed ID: 35246237
[TBL] [Abstract][Full Text] [Related]
11. Descriptive Longitudinal Analysis of Stereotypy and Corresponding Changes in Psychotropic Medication.
Piersma D; Aguilar M; Seibert H; Boyle B; Griffith G; Valdovinos MG
Dev Neurorehabil; 2022 Jul; 25(5):298-308. PubMed ID: 34865596
[TBL] [Abstract][Full Text] [Related]
12. Stereotypies in the Autism Spectrum Disorder: Can We Rely on an Ethological Model?
Keller R; Costa T; Imperiale D; Bianco A; Rondini E; Hassiotis A; Bertelli MO
Brain Sci; 2021 Jun; 11(6):. PubMed ID: 34201177
[TBL] [Abstract][Full Text] [Related]
13. Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis.
Siafis S; Çıray O; Schneider-Thoma J; Bighelli I; Krause M; Rodolico A; Ceraso A; Deste G; Huhn M; Fraguas D; Mavridis D; Charman T; Murphy DG; Parellada M; Arango C; Leucht S
Mol Autism; 2020 Aug; 11(1):66. PubMed ID: 32847616
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological targeting of striatal indirect pathway neurons improves subthalamic nucleus dysfunction and reduces repetitive behaviors in C58 mice.
Muehlmann AM; Maletz S; King MA; Lewis MH
Behav Brain Res; 2020 Aug; 391():112708. PubMed ID: 32461129
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy of restricted/repetitive behavior in autism spectrum disorder:a systematic review and meta-analysis.
Yu Y; Chaulagain A; Pedersen SA; Lydersen S; Leventhal BL; Szatmari P; Aleksic B; Ozaki N; Skokauskas N
BMC Psychiatry; 2020 Mar; 20(1):121. PubMed ID: 32164636
[TBL] [Abstract][Full Text] [Related]
16. Reduction of repetitive behavior by co-administration of adenosine receptor agonists in C58 mice.
Lewis MH; Rajpal H; Muehlmann AM
Pharmacol Biochem Behav; 2019 Jun; 181():110-116. PubMed ID: 31054946
[TBL] [Abstract][Full Text] [Related]
17. The neural circuitry of restricted repetitive behavior: Magnetic resonance imaging in neurodevelopmental disorders and animal models.
Wilkes BJ; Lewis MH
Neurosci Biobehav Rev; 2018 Sep; 92():152-171. PubMed ID: 29802854
[TBL] [Abstract][Full Text] [Related]
18. Dosing and Monitoring: Children and Adolescents.
Hirsch GS
Psychopharmacol Bull; 2018 Feb; 48(2):34-92. PubMed ID: 29713099
[No Abstract] [Full Text] [Related]
19. Automated Detection of Repetitive Motor Behaviors as an Outcome Measurement in Intellectual and Developmental Disabilities.
Gilchrist KH; Hegarty-Craver M; Christian RB; Grego S; Kies AC; Wheeler AC
J Autism Dev Disord; 2018 May; 48(5):1458-1466. PubMed ID: 29164446
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of the processes used to link clinical trial registrations to their published results.
Bashir R; Bourgeois FT; Dunn AG
Syst Rev; 2017 Jul; 6(1):123. PubMed ID: 28669351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
